期刊
CANCERS
卷 11, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/cancers11040433
关键词
colorectal; cancer; kinases; receptor; target
类别
资金
- Junta de Andalucia [16/0298]
- Fondo Europeo de Desarrollo Regional (FEDER)
- Instituto de Salud Carlos III [18/01181]
Colorectal cancer is the third most common malignancy in men and the second most common cancer in women. Despite the success of screening programs and the development of adjuvant therapies, the global burden of colorectal cancer is expected to increase by 60% to more than 2.2 million new cases and 1.1 million deaths by 2030. In recent years, a great effort has been made to demonstrate the utility of protein kinase inhibitors for cancer treatment. Considering this heterogeneous disease is defined by mutations that activate different Receptor Tyrosine Kinases (RTKs) and affect downstream components of RTK-activated transduction pathways, in this review we analyze the potential utility of different kinase inhibitors for colorectal cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据